OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vulvovaginal Candidiasis
Species associated with recurrent episodes tend to be less azole susceptible
July 4th, 2005
Species of Candida associated with recurrent episodes of vulvovaginal candidiasis tend not to be C. albicans and less susceptible to effective treatment by azole drugs, research shows. "There are limited data regarding the antifungal susceptibility of yeast causing vulvovaginal candidiasis, since cultures are rarely performed," wrote Sandra S. Richter and colleagues, University of Iowa. "Susceptibility testing was performed on vaginal yeast isolates collected from January 1998 to March 2001 from 429 patients with suspected vulvovaginal candidiasis. The charts of 84 patients, with multiple positive cultures, were reviewed," according to...
Source: OBGYN & Reproduction Week (2005-07-04)
|
